View Author
tumor patient cancer expression protein mesothelioma exosome study treatment response tumour immunotherapy group nk cells dendritic macrophage figure effect analysis survival pemetrexed level dendritic cells culture function nsclc lysate antigen tumour-bearing mice number celecoxib control pmr-mm reduction myeloid journal production immunol table injection subset splenocyte subtype gene expression dc-based immunotherapy marker netherland factor fev 1 blood tumor cells effusion therapy month vaccination signi cytokine myeloid cells load reduction model hbv patients population activation tumour-bearing cox -2 expression chromosomal dc immunotherapy region disease t cells spleen growth fication change identi 6 months m 2 macrophages tissue membrane pmr-mm 7
10 Most Recent Publications
|
Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy
(Article)
Hou, J. Lambers, M.E.H. Den Hamer, B. Bakker, M.A. den Hoogsteden, H.C. Grosveld, F.G. Hegmans, J.P. Aerts, J.G.J.V. Philipsen, S. |
2012-01-01
|
|
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Hendriks, R.W. Hoogsteden, H.C. Aerts, J.G.J.V. Hegmans, J.P. |
2010-08-30
|
|
Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Hendriks, R.W. Hoogsteden, H.C. Hegmans, J.P. Aerts, J.G.J.V. |
2010-08-01
|
|
Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activitys
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Jong, S. de Hendriks, R.W. Hoogsteden, H.C. Aerts, J.G.J.V. Hegmans, J.P. |
2010-06-18
|
|
Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma
(Article)
Hegmans, J.P. Veltman, J.D. Lambers, M.E.H. Vries, I.J.M. de Figdor, C.G. Hendriks, R.W. Hoogsteden, H.C. Lambrecht, B.N.M. Aerts, J.G.J.V. |
2010-06-15
|
|
Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B
(Article)
Tjwa, E.T.T.L. Oord, G.W. van Hegmans, J.P. Janssen, H.L.A. Woltman, A.M. |
2010-01-01
|
|
Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines
(Article)
Zanazzi, C. Hersmus, R. Looijenga, L.H.J. Veltman, I. Gillis, A.J. Drunen, E. van Beverloo, H.B. Hegmans, J.P. Verweij, M. Lambrecht, B.N.M. Oosterhuis, J.W. |
2007-10-01
|
|
HIF1a expression in bronchial biopsies correlates with tumor microvascular saturation determined using optical spectroscopy
(Article)
Aerts, J.G.J.V. Amelink, A. Leest, K.H. van der Hegmans, J.P. Hemmes, A. Hamer, B.d. Sterenborg, H.C.J.M. Hoogsteden, H.C. Lambrecht, B.N.M. |
2007-09-01
|
|
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
(Article)
Hegmans, J.P. Hemmes, A. Aerts, J.G.J.V. Hoogsteden, H.C. Lambrecht, B.N.M. |
2005-05-15
|
|
Proteomic analysis of exosomes isolated from human malignant pleural effusions.
(Article)
Bard, M.P.L. Hegmans, J.P. Hemmes, A. Luider, T.M. Willemsen, R. Severijnen, L.A. Meerbeeck, J.P. van Burgers, S.A. Hoogsteden, H.C. Lambrecht, B.N.M. |
2004-07-01
|
